University of Sharjah

Statins Linked to 61% Reduced Cancer Mortality in CLL/SLL Patients on Targeted Therapy

22 days ago

• Groundbreaking research reveals patients with chronic lymphocytic leukemia or small lymphocytic lymphoma taking statins showed 61% lower cancer mortality and 38% reduced all-cause mortality when receiving targeted therapies like ibrutinib. • The collaborative study analyzed data from 1,467 patients across four international clinical trials conducted between 2012-2019, finding statin use was also associated with 26% lower disease progression without increasing severe side effects. • Researchers from University of Sharjah and Burjeel Cancer Institute caution that while promising, these observational findings require confirmation through dedicated clinical trials before statins can be recommended as supportive cancer treatment.